Bavarian Nordic gets U.S. contract; Price of Novartis' Bexsero could be problematic;

> Los Angeles health officials and charities are offering free meningitis vaccines after a man died of the disease last week. News

> Bavarian Nordic has secured a $228 million supply deal with the U.S. for the smallpox vaccine that accounts for the bulk of its sales. Article

> Research suggests T cells play a protective role in the immune response against dengue fever and should be factored into vaccine design. Study

> Medicago has reported that its H5N1 vaccine was well tolerated in a Phase I trial. Release

> Research firm GlobalData has warned that cost-effectiveness concerns may stop governments from adding Novartis' ($NVS) Bexsero to vaccination programs. Item

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.